Alyssa Eisenberg, PharmD, explores technology’s emerging role in the health care environment and how the pharmacist of the future’s day-to-day tasks might evolve.
|Slideshows|June 11, 2019
- Drug Topics June 2019
- Volume 163
- Issue 6
Maintain Control of Controlled Substances
Author(s)Natalia Mazina, JD
Comply with state and federal regulations on dispensing and handling controls to avoid possible disciplinary or DEA actions and penalties.
Advertisement
Articles in this issue
over 7 years ago
Opinion: Data is a Vital Resource in Fighting the Opioid Crisisover 7 years ago
Why Technology Upkeep is Up to Youover 7 years ago
Five Tech Best Practicesover 7 years ago
New Drug Review: Zulresso (Brexanolone)over 7 years ago
Opinion: The Future of Pharmacyover 7 years ago
Discount Drug Cards Are Flourishingover 7 years ago
How to Keep Your Professional Development Currentover 7 years ago
10 Ways to Boost Customer Loyaltyover 7 years ago
Opinion: PharmD Quality vs Quantityover 7 years ago
On the Road to Provider StatusAdvertisement
Related to this article
In the final portion of our discussion with Kimberly Kue-Tsemo, PharmD, she explores the key developments that could be the most significant push toward reducing pharmacy deserts.
In the second part of our interview with a collection of pharmacists from various backgrounds, they delve into the current developments highlighting the future of the profession.
Phase 2 trial results for the investigational vaccine were presented at IDWeek 2026 in Washington, DC, as the phase 3 program is currently underway.
The finalized rule is another step in the right direction for pharmacies calling for reform due to underwater reimbursement and other PBM pressures.
Allison Schneider, MPH, provides a detailed update regarding pharmacies’ impact within Medicare price negotiations and the legislation further impacting businesses.
The US health department announced policies that will allow for the compounding of 6 key peptides in US pharmacies.
New survey data add to the evidence regarding the safe and effective route of administering both COVID-19 and flu vaccines simultaneously.
Advertisement
Advertisement
Trending on Drug Topics
1
American Pharmacists Month: Technology’s Role in Expanding Pharmacist Scope
2
PBMs Must Now Disclose Fees to Employer Plans Under Final DOL Rule
3
HHS Lets Pharmacies Compound Peptides as FDA Writes Official Rule
4
Pharmacy Law Lowdown: Defending Against PBM Inventory Audits
5